Pritesh Shah, Chief Commercial Officer at NovoCure Ltd (NVCR), sold 12,302 shares at $130.81 ($1.6M) on 2021-03-08, disclosed to the SEC on 2021-03-10.
Open-market sale of $1.6M NVCR by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $130.81 | 2,627 | $344K | 21.3% |
| 2 | $130.81 | 2,627 | $344K | 21.3% |
| 3 | $131.09 | 3,524 | $462K | 28.7% |
| 4 | $131.09 | 3,524 | $462K | 28.7% |
| Total | $130.97 avg | 12,302 | $1.6M | 100% |
| Filing → |
| NVCR | SELL | 2023-03-07 | $3.3M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $141K | — | Filing → |
| NVCR | SELL | 2023-03-02 | $294K | — | Filing → |